Biotech News

RxSight, Inc. to Participate in the 25th Annual Needham Virtual Healthcare Conference

RxSight (RXST)RxSight2026-04-02 20:10 ESTConference / presentation

ALISO VIEJO, Calif., April 02, 2026 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RxSight, Inc., today announced plans to participate in the upcoming 25th Annual Needham Virtual Healthcare Conference. Management is scheduled to participate in a fireside chat on Thursday, April 16, 2026, at 8:00 a.m.

Open original release

Related news

RXSTRxSight2026-04-29 20:10 EST

RxSight, Inc. to Present at the Bank of America Healthcare Conference

PLSEPulse Biosciences2026-04-02 20:05 EST

Pulse Biosciences to Present at the 25th Annual Needham Virtual Healthcare Conference

ANGOAngioDynamics2026-03-31 12:00 EST

AngioDynamics to Present at the 25th Annual Needham Virtual Healthcare Conference

SGHTSight Sciences2026-03-30 20:05 EST

Sight Sciences to Present at the 25th Annual Needham Healthcare Conference on April 13th

HYPRHyperfine2026-05-06 20:05 EST

Hyperfine, Inc. to Participate in Upcoming 2026 Jefferies Global Healthcare Conference

IARTIntegra LifeSciences2026-06-02 11:30 EST

Integra LifeSciences to Present at the 2026 Jefferies Global Healthcare Conference

CVRXCVRx2026-05-27 20:30 EST

CVRx to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

PLSEPulse Biosciences2026-05-27 20:05 EST

Pulse Biosciences to Present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026

ATRCAtriCure2026-05-27 12:00 EST

AtriCure to Participate in the Goldman Sachs 47th Annual Global Health Care Conference

DCTHDelcath Systems2026-05-12 12:00 EST

Delcath Systems to Participate at the H.C. Wainwright 4th Annual BioConnect Investor Conference

View all latest news

RxSight

RxSight is a medical device company focused on adjustable intraocular lenses for cataract surgery. Its business is built around ophthalmic procedure adoption and premium eye-care technology.

Recent company news

RXSTRxSight2026-05-19 20:10 EST

RxSight, Inc. to Present at the Stifel 2026 Virtual Ophthalmology Forum

RXSTRxSight2026-05-06 20:05 EST

RxSight, Inc. Reports First Quarter 2026 Results and Reiterates Full-Year Sales Outlook

RXSTRxSight2026-04-29 20:10 EST

RxSight, Inc. to Present at the Bank of America Healthcare Conference

RXSTRxSight2026-04-22 20:10 EST

RxSight, Inc. to Report First Quarter 2026 Financial Results on May 6

RXSTRxSight2026-04-08 20:05 EST

RxSight Highlights 300,000 Light Adjustable Lens Implant Milestone and Strong Scientific Presence at ASCRS 2026

Stock data

Close: 5.64 USD
Market cap: 204.5M USD
Exchange: NASDAQ
Sector: Biopharma
Location: United States